Citadel Advisors »

Nls Pharmaceutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Nls Pharmaceutics (NLSPW) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Nls Pharmaceutics

Tip: Access up to 7 years of quarterly data

All positions including Nls Pharmaceutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nls Pharmaceutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $481 16k 0.03

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Tesla Motors Call Option (TSLA)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Advanced Micro Devices Call Option (AMD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Citadel Advisors

Top funds holding Nls Pharmaceutics

Armistice Capital
Altium Capital Management
Hudson Bay Capital Management
Citadel Advisors
Susquehanna International
Clear Street

View all funds holding Nls Pharmaceutics